Latest Headlines

Latest Headlines

Stupak plays bad cop against pharma

In light of the ancient advice to know your adversary, we present a profile of Rep. Bart Stupak (photo), the Michigan Democrat

Lipitor doc doesn't practice rowing, either

Dr. Robert Jarvik (photo) has already

Vytorin, Zetia scrips plummet

Ready for a quantitative look at how the Enhance study affected public attitudes toward the meds in

Full speed ahead for Vytorin II at Merck, Schering

The disastrous results of the recent Vytorin study have apparently done nothing to blunt the appetites

It's Crestor vs. Lipitor in AZ trial

If GlaxoSmithKline can challenge Merck to a head-to-head trial (Cervarix versus Gardasil), then AstraZeneca

Lipitor patent gets U.S. thumbs-down

Oh, the tangled web of Lipitor patent claims and counterclaims. Today, Pfizer announced that the U.S.

Schering CEO defends Vytorin decisions

Talk about the hot seat. At a Morgan Stanely pharma conference yesterday, Schering-Plough CEO Fred Hassan (photo) was

ALSO NOTED: Investors sue Sanofi over Acomplia, again; Teva gets UK nod for copycat migraine med;

> Investors have filed a second  class action suit against Sanofi-Aventis, alleging that the company misled them about the

Novartis CEO's statin? Pfizer's Lipitor

What's a pharma CEO with high cholesterol to do? Take his company's statin, of course. But Novartis chief Daniel Vasella (

Pharma layoffs set new record

You can't talk 2007 in the drug industry without mentioning the L word: layoffs. Everyone who's anyone in pharma these